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Abstract 
Problem  Adolescents are contracting sexually transmitted infections (STIs) with half of 
all new STIs occurring in those aged 15-24 years old. The American Academy of 
Pediatrics, recommended all sexually active adolescents be screened for STIs. 
Incorporation of a sexual behavior assessment may assist providers with identifying STI 
risk. 
Methods  A descriptive design comparing three cohorts of adolescents presenting for a 
well-exam. The cohorts analyzed were: urine screening on all adolescents, urine 
screening for only those reporting sexual activity, and a self-administered sexual history 
questionnaire tool, based on the HEEADSSS psychosocial assessments. 
Results  The majority (97%), of all three cohorts (N=60), had a documented sexual 
history in the medical record. A chi-square analysis between cohort one and two (n=49) 
comparing sexual history and urine STI testing (χ2 = 5.72, p = .057), and comparing urine 
STI testing with a positive urine test (χ2 = 0.04, p = .837) was essentially unremarkable. 
A statistical analysis could not be conducted comparing cohort three with cohort one or 
cohort two due to incomplete sampling. Overall, about 20% tested positive for an STI 
when screened routinely or if the adolescent reported sexual activity.  
Implications For Practice  Urine screening for STI improved the identification of  an STI 
in adolescents and is of clinical significance. Assessment of sexual activity and STI risk 
may be improved when private time between the adolescent and provider are available, or 
through a paper assessment tool completed by the adolescent without a parent present.              
 
 
ADOLESCENT STI SCREENINGS 3 
Screening For Sexually Transmitted Infections In Adolescents 
Because of high-risk behaviors, adolescents are at an increased risk of exposure to 
sexually transmitted infections (STIs). According to the Centers for Disease Control and 
Prevention (CDC), youth aged 15-24 years old account for half of the 20 million new 
STIs occurring in the US each year (CDC, 2017). Chlamydia trachomatis (chlamydia) 
and Neiserria gonorrhoae (gonorrhea) are the most common STIs reported in the 
adolescent population (CDC, 2017). The 2017 STI Surveillance Report, reported 62% of 
chlamydia infections where diagnosed in those aged 15-24 years old (CDC, 2017). 
Additionally, the CDC (2017) reported the rate of gonorrhea infections increased by 15% 
between 2016 and 2017 in the adolescent population. Hence, adolescents are engaging in 
high-risk sexual behaviors and contracting STIs at an alarming rate.  
 Despite these facts, STI screenings in the adolescent population may be 
inconsistent within the primary care setting. Many adolescents are reluctant to disclose 
sexual activity to their medical providers. Adolescents may be accompanied by a 
caregiver and the opportunity for time alone with providers is limited or nonexistent, 
concerns about confidentiality, and perceived stigma are all associated with adolescents’ 
failure to disclose sexual activity (Cuffe, Newton-Levinson, Gift, McFarlane, & 
Leichliter, 2016). For these reasons and more, testing for STIs, early treatment, and 
education for risk reduction are delayed. When left untreated, STIs can lead to long-term 
complications such as pelvic inflammatory disease and infertility (AAP, 2014). Primary 
care providers have an opportunity to influence the sexual and reproductive health of 
adolescents.    
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 The American Academy of Pediatrics (AAP) publication, Bright Futures 
Guidelines for Health Supervision of Infants, Children, and Adolescents, recommended 
screening for chlamydia and gonorrhea in all sexually active teens (AAP, 2017). A 
comprehensive psychosocial screening tool, the HEEADSSS (Home, Education, Eating, 
Activities, Drugs and Alcohol, Suicide and Depression, Sexuality and Safety) assessment, 
contains interview questions to assist providers in collecting a psychosocial history of the 
adolescent, including sexuality (Smith & McGuinness, 2017). This psychosocial 
assessment framework was first introduced by pediatrician Dr. Henry S. Berman in the 
1970s. Over time, the evaluation questions have evolved to reflect current risk factors 
that affect the adolescent population and to help providers address psychosocial issues in 
a confidential and unbiased manner (Smith & McGuinness, 2017).  
 Testing for chlamydia and gonorrhea can be done easily using nucleic acid 
amplification tests (NAATs). NAATs have a high sensitivity and specificity for detecting 
these infections (AAP, 2017). Specimens can be collected through urine sample, urethral, 
vaginal, and/or cervical swabs. In the pediatric population, urine collection is the least 
invasive method, easily obtained, and less intimidating. Gonorrhea and chlamydia can 
usually be ordered as a combined test and completed on a single specimen (AAP, 2017). 
The AAP recommended all sexually active adolescents receive chlamydia and gonorrhea 
testing annually (AAP, 2017).       
Current practice at a Midwestern, suburban, organizationally-owned pediatric primary 
care office is to collect adolescent sexual histories with parents at the bedside. In general, 
adolescents are not given private time with providers which may influence disclosure of 
high-risk behavior. At one time, a urine chlamydia or gonorrhea diagnostic test had been 
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performed on all adolescents, and at another time the urine test was reserved for those 
who had disclosed active sexual activity. The purpose of this quality improvement 
initiative was to assess for STI risk by implementing a self-administered sexual history 
questionnaire tool, based on the HEEADSSS psychosocial assessment, and perform a 
reflexive urine test if sexual risk was indicated. The primary aim was to improve STI 
screening and urine testing for adolescents at high risk within the practice. The questions 
of study were: During a well-child exam in adolescents aged 13-17 years, 
1. What was the overall number of adolescents seen for a well-child exam from 
February-March 2018 (cohort one), August-September 2018 (cohort two), and 
February-March 2019 (cohort three)? 
2. What was the number of those screened for an STI with a urine chlamydia and 
gonorrhea diagnostic test from February through March 2018 (cohort one)? 
3. What is the number of those screened for an STI with a urine chlamydia and 
gonorrhea diagnostic test only when sexual activity was disclosed from August 
through September 2018 (cohort two)? 
4. Of those screened with a urine chlamydia and gonorrhea test in cohort one and 
cohort two in 2018, how many tested positive for one or both diseases? 
5. What was the number of those screened with the modified HEEADSSS 
questionnaire from February through March 2019 (cohort three)? 
6. Of those who were screened with the modified HEEADSSS questionnaire in 2019 
(cohort three), how many were found to be at risk for an STI? 
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7. Of those who were found to be at risk for an STI with the modified HEEADSSS 
questionnaire in 2019 (cohort three), how many had a urine chlamydia and 
gonorrhea test performed? 
8. What was the rate of positive STI infection identified by urine testing between the 
three cohorts? 
Review of Literature 
A systematic literature review included the databases of Summon, PubMed, 
CINAHL, Google Scholar, and the Cochrane Library. The key words used were sexually 
transmitted infections, adolescents, screenings, primary care, chlamydia, gonorrhea, 
HEEADSSS, and psychosocial assessments. The literature review included research 
articles and studies from 2008 through 2018. The search was filtered for full text articles 
published in English, journal articles, and scholarly peer-reviewed publications. Articles 
were excluded if they were not related to the adolescent population, chlamydia 
trachomatis, and/or gonorrhea. Ultimately, 14 publications were chosen for this literature 
review. 
 Several organizations have released evidence-based practice guidelines and 
recommendations on STI screenings and treatment in adolescents (AAP, 2014; CDC, 
2017, US Preventative Services Task Force [USPSTF], 2014). All agreed sexually active 
adolescents should be tested annually for chlamydia and gonorrhea. Despite these 
recommendations and guidelines, rates of chlamydia and gonorrhea remain highest 
among adolescents (CDC, 2017). Hence, opportunities exist in preventative sexual and 
reproductive health care that is provided to adolescents. 
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 Office visits present opportunities for primary care providers to educate 
adolescents on sexual health. Schneider, FitzGerald, Byczkowski, and Reed (2016) 
conducted a study in a pediatric emergency department collecting urine samples for 
chlamydia and gonorrhea from 403 asymptomatic adolescents with non-genitourinary 
complaint. About 10% (n=40) were positive for at least one STI; moreover, about 90% of 
the subjects acknowledged having a primary care provider (Schneider et al., 2016). 
Because adolescents engage in high-risk sexual behaviors, vigilance in screening, 
identifying, and treating STI infections in adolescents in the primary care setting is 
recommended (AAP, 2017). While prevention is a primary goal, addressing the sexual 
and reproductive health needs of adolescents cannot be ignored (AAP, 2017).  
 Sexual activity is common in adolescence. Goyal, Witt, Hayes, Zaoutis, & Gerber 
(2014) conducted a study on clinical providers screening adolescents for sexual activity 
and STIs. Their study was conducted across 29 pediatric primary care offices and 
included a retrospective cross-sectional study of randomly selected adolescents, aged 13- 
to 19-years (Goyal et al., 2014). From 1,000 well-child encounters reviewed, only 21% 
(n=212) of adolescents had a documented sexual history and 21% (n=45) of those 
adolescents were identified as being sexually active; however, only 33% (n=15) of the 
adolescents documented as sexually active received testing for chlamydia and gonorrhea 
(Goyal et al., 2014). Goyal et al. (2014) found greater than 50% of the sexually active 
adolescents in their study did not get recommended STI testing. Additionally, nearly 80% 
of adolescent well-child visits reviewed did not have a sexual history documented (Goyal 
et al., 2014). Thus, when sexual histories are unknown, a missed opportunity for STI 
testing exists, and appropriate treatment does not occur. 
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 Adolescents may feel invincible about acquiring an STI. Cuffe et al. (2016) 
surveyed over 3,000 adolescents and found 11.5% reported receiving an STI test in the 
last 12 months, and 34% reported having an STI test as part of their routine health visit. 
Of those sexually active and never tested, 41.8% did not seek testing on their own 
because of believing they were not at risk for an STI (Cuffe et al., 2016). Some 
adolescents (32.5%) reported not seeking STI testing because their medical provider did 
not suggest it (Cuffe et al., 2016). Adolescents may be influenced to be tested for an STI 
when a medical provider recommends it. Early identification of an STI may result in 
early treatment thereby preventing long-term sequelae. 
 Several barriers exist to adolescent STI screening and understanding them may 
clarify why there is a lack of screening and testing in this population. The largest barrier 
in preventing an adolescent from disclosing sexual activity and seeking STI screening, 
may be related to their concerns of confidentiality (Cuffe, Newton-Levinson, Gift, 
McFarlane, & Leichliter, 2016; Fuentes, Ingerick, Jones, & Lindberg, 2018; Marcell, & 
Burstein, 2017). Adolescents may fear adult judgement. To minimize confidentiality 
concerns, recommendations included using psychosocial assessment tools that screen for 
high-risk behaviors specifically addressing sexual activity (Bradford & Rickwood, 2012). 
Furthermore, screening tools conducted through private interview, pen/paper assessment 
tools, and technology devices on tablets and iPads were recommended (Bradford & 
Rickwood, 2012). 
 Respecting confidentiality gains trust from an adolescent. Kadivar et al. (2014) 
demonstrated adolescents were more likely to answer screenings with more honesty when 
done confidentially. In a systematic review by Bradford and Rickwood (2012), self-
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administered tools were found to be the most accepted amongst adolescents, and their use 
improved engagement with the healthcare provider. Despite confidential screening with a 
self-administered tool, some practitioners did not complete follow-up with the adolescent 
on potential risks (Bradford & Rickwood, 2012). 
 The use of validated, standardized screening instruments can be beneficial for 
increasing the effectiveness of the care provided in busy primary care practices. Eade and 
Henning (2013) found the use of a comprehensive youth assessment tool, such as the 
HEADSS assessment tool, facilitated STI screenings. In their study, 85 adolescents had 
completed a HEADSS assessment with half (n=43) of the adolescents being screened for 
chlamydia due to identified risk, resulting in 25% (n=11) of them having a positive result 
(Eade & Henning, 2013). Incorporating high-risk behavior assessment tools may assist 
providers with education, testing, and treatment needed to improve health care for 
adolescents.                                   
The framework to guide this clinical scholarship project was based on the 
Donnebedian model of structure, process, outcomes. Specifically, the Plan-Do-Study-Act 
(PDSA) was selected. The PDSA cycle is a four-step model for improving a process. The 
“plan” phase of this cycle involves developing a test for change. The “do” phase of this 
model is to implement the plan and document data. The “study” phase is to evaluate the 
data and determine if the plan was beneficial. The “act” phase involves adopting, 
adapting, and/or adjusting the intervention (Christoff, 2018).  The PDSA is the most 
commonly used tool in healthcare quality improvement (Christoff, 2018). Utilizing the 
PDSA cycle to implement change has resulted in significant improvements in care and 
patient outcomes (Christoff, 2018).   
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Method  
Design 
 An observational, descriptive, cohort design was utilized. The PDSA cycle to test 
the change of implementing a modified HEEADSSS assessment was done. The modified 
HEEADSSS assessment implementation began in February and ended in March 2019. In 
addition, a retrospective medical record review was done from February-March 2018, 
August-September 2018, and February-March 2019 to assess the effectiveness of 
screening all adolescents, screening only those who disclose sexual activity, and 
screening those who indicate sexual activity on a written assessment. A chlamydia and 
gonorrhea urine diagnostic test was used to compare results for identifying adolescents at 
risk for and/or who had an STI.   
Setting 
 An organizationally-owned, pediatric primary care office located in a Midwestern 
suburb of a metropolitan area was selected for this study. This practice provided pediatric 
primary care services as well as behavioral health therapy services. Care was provided to 
those aged 0- through 18-years old. The practice consisted of two pediatricians, one 
pediatric nurse practitioner, one clinical social worker, three medical assistants, and two 
staff nurses. According to the most recent census, the estimated population of the service 
area is 41,649 with nearly 28% of the population being under 18 years of age (U.S. 
Census Bureau, 2017). Caucasians represent 69% of the population, African Americans 
25%, Latinos 2%, and other races representing less than 1% (U.S. Census Bureau, 2017).   
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Sample 
A retrospective record review was conducted on a convenience sample of 
adolescents during a well-child visit during three different periods in time. There were 
three cohorts: Cohort 1 representing practice with urine screening for STI was done on all 
adolescents, Cohort 2 representing practice with urine screening for STI was only done 
on adolescents reporting to be sexually active, and Cohort 3 representing practice 
utilizing a modified HEEADSSS assessment tool and a reflexive urine screening for STI. 
Inclusion criteria was 13-17 years of age; able to read, understand, and answer questions 
on the questionnaire; and scheduled for a well-child visit. Exclusion criteria was less than 
13- or greater than 17-years of age; unable to read, understand, and/or answer questions 
on a questionnaire.  
Procedures   
 A team of key stakeholders was formed and included the site manager, staff 
pediatric nurse practitioner, and medical assistants. After review and discussion of the 
current STI screening process, the modified HEEADSSS assessment was selected as the 
additional screening tool and if positive, a reflexive urine test would be performed. A 
modified HEEADSSS assessment was offered at the beginning of the visit to those who 
met inclusion criteria; however, the adolescent had the choice to complete (or not) the 
pen/paper assessment on their own. If completed, the modified HEEADSSS assessment 
was reviewed by the medical provider. If the questionnaire was found to indicate sexual 
activity or risk for STI, a chlamydia and gonorrhea urine diagnostic test was ordered.   
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Data Collection & Analysis 
All data was retrieved from a retrospective medical record review. Demographic 
data included age, gender, and race/ethnicity. Additional data included a modified 
HEEADSSS assessment completion, urine diagnostic testing completion, and urine 
diagnostic testing results. Data was stored and collected on a password-protected 
computer and flash drive. All personal identifiers were removed and data was coded as 
18-1, 18-2, 18-3, etc. and 18-1a, 18-2a, 18-3a, etc. for those records reviewed from 2018. 
In addition, 19-1, 19-2, 19-3, etc., for those records reviewed in 2019. Data was analyzed 
using descriptive and chi-square statistics.    
Approval Processes 
 Administrative approval for project implementation was obtained from the 
pediatric primary care practice. Approvals from the doctor of nursing practice (DNP) 
committee, institutional review board (IRB), and graduate school from the University 
were obtained. There was minimal to no risk to the adolescents as this was retrospective 
medical record review. Parental consent was not needed due to state law requirements of 
those 12-years and older not needing parental permission to authorize health care services 
for the diagnosis and/or treatment of STIs (410 ILCS 210/4). Benefits of STI screening of 
adolescents included early identification and treatment of STIs. 
Results 
 A retrospective medical record review was conducted with three cohorts (N=60): 
(1) February – March 2018 (representing practice with urine screening for STI on all 
adolescents), (2) August – September 2018 (representing practice with urine screening 
for STI only on adolescents reporting to be sexually active), and (3) February – March 
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2019 (representing practice utilizing a modified paper HEEADSSS assessment tool and 
reflexive urine screening for STI). In the first cohort, 16 adolescent medical records were 
reviewed (n=16). The age of the adolescent ranged from 13- to 17-years, with a mean age 
of 15 (sd=1.5) years with the most frequently occurring age being 13-years. Of these 16 
adolescents, 56% were female (n = 9) and 44% were male (n=7).  Adolescent 
race/ethnicity were White (n = 7, 44%), Black (n=6, 37%), and Hispanic (n=3, 19%) in 
this cohort. All adolescents had a sexual history documented by the provider (n = 16).  
Just over 6% (n=1) were documented as being sexually active, 87.5% (n=14) were 
documented as not being sexually active, and 6% (n=1) neither reported nor denied 
sexual activity. Nearly 56% (n=9) of the adolescents had a urine screen for STI 
completed while 44% (n=7) did not.  Of the nine urine screens, 22% (n=2) had urine 
testing positive for an STI (Appendix A). 
In the second cohort, 33 medical records were reviewed (n=33). The age of the 
adolescent ranged from 13- to 17-years, with a mean age of 15 (sd=1.2) years with the 
most frequently occurring age being 14-years.  Of these 33 adolescents, 45% were female 
(n = 15) and 55% were male (n=18).  Adolescent race/ethnicity were White (n = 10, 
30%), Black (n=17, 52%), Hispanic (n=4, 12%), and Other (n=2, 6%) in this cohort. 
Nearly 94% of these adolescents had a sexual history documented by the provider (n = 
31) while two (6%) did not.  Only 15% (n=5) were documented as being sexually active, 
79% (n=26) were documented as not being sexually active, and 6% (n=2) neither 
reported nor denied sexual activity. Nearly 84% (n=5) of the adolescents had a urine 
screen for STI completed while one (17%) did not.  Of the five urine screens, 20% (n=1) 
had urine testing positive for an STI (Appendix B). 
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The combination of cohorts one and two (n=49) represent the comparison sample 
for the effectiveness of the HEEADSSS assessment and reflexive urine screening for STI. 
Within these first two cohorts, the age of the adolescent ranged from 13- to 17-years, 
with a mean age of 15 (sd=1.3) years with the most frequently occurring age being 14-
years.  Of these 49 adolescents, 49% were female (n = 24) and 51% were male (n=25). 
Adolescent race/ethnicity were White (n = 17, 35%), Black (n=23, 47%), Hispanic (n=7, 
14%), and Other (n=2, 4%) in this sample. Nearly 94% of these adolescents had a sexual 
history documented by the provider (n = 46) while three (6%) did not.  Only 12% (n=6) 
were documented as being sexually active, 82% (n=40) were documented as not being 
sexually active, and 6% (n=3) neither reported nor denied sexual activity. Nearly 29% 
(n=14) of the adolescents had a urine screen for STI completed while 71% (n=35) did 
not.  Of the 14 urine screens, 21% (n=3) had urine testing positive for an STI and nearly 
79% (n=22.5) were negative for STI (Appendix C). 
The third cohort represented HEEADSSS assessment and a reflexive STI urine 
screen (n=11) for which the combined first two cohorts were compared. Within this 
cohort, the age of the adolescent ranged from 13- to 17-years, with a mean age of 15 
years (sd=1.5) years with the most frequently occurring age being 14-years.  Of these 11 
adolescents, 36% were female (n=4) and 64% were male (n=7).  Adolescent 
race/ethnicity were White (n = 1, 9%), Black (n=9, 82%), and Hispanic (n=1, 9%). All 11 
of these adolescents had a sexual history documented by the provider that was collected 
using the modified HEEADSSS assessment tool on a paper document. Only 9% (n=1) 
reported being sexually active, 90% (n=10) reported not being sexually active. One 
adolescent had a urine screen for STI ordered while 90% (n=9) did not (Appendix D).  
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A chi-square test was conducted on the combinations of cohort one and two 
(n=49) to compare sexual history and STI urine testing. There was no statistical 
difference between the samples regarding the rate of STI urine screening on all 
adolescents when compared to urine screening on only those who disclosed sexual 
activity (χ2 = 5.72, p = .057) (Appendix E). A second chi-square test was conducted with 
the same cohorts’ comparing the rate of STI urine testing and those testing positive on the 
urine test. There was no difference in the rate of urine testing positive between those who 
were automatically screened and those who were screened only if sexual activity was 
disclosed (χ2 = 0.04, p = .837) (Appendix F). A statistical analysis could not be conducted 
between cohort three with cohort one or cohort two due to the lack of urine results for the 
third cohort. 
Discussion 
There were 60 adolescent well-child visits during the selected periods of study 
with an average age of 15-years.  The first cohort resulted in 16 patients for whom STI 
urine screening was routine for all adolescent patients regardless of the report of sexual 
activity. The second cohort resulted in 33 patients where STI urine screening was only 
performed on those reporting sexual activity. Finally, the third cohort resulted in 11 
patients screened with the modified HEEADSSS assessment and reflexive STI urine 
screen.  
All three cohorts demonstrated a majority (97%) of adolescent patients had a 
documented sexual history in the medical record during the study periods and is clinically 
significant. Because the practice did not typically provide private time between the 
provider and the adolescent, most adolescents denied sexual activity (83%). In addition, 
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all STI risk assessments and sex histories were performed with the parents at the bedside. 
In the first cohort, all patients had a sexual history documented with nearly 88% denying 
sexual activity, one reported sexual activity, and one neither reported nor denied sexual 
activity. However, two of the adolescents who denied sexual activity had a positive urine 
screen for chlamydia. In the second cohort, nearly 79% denied sexual activity, 15% 
reported sexual activity, and two patients neither reported or denied sexual activity.  
Finally, nearly all adolescents screened with the HEEADSSS assessment and reflexive 
STI urine screen in the third cohort denied being sexually active. Hence, most 
adolescents denied sexual activity when caregivers were present. Sexual activity and STI 
risk may have been more accurately identified if confidential, private time between the 
adolescent and provider were available. Furthermore, a paper assessment tool or 
technology device provided to and completed by the adolescent without a parent present 
may have provided some privacy for the adolescent.  
During the study period for the first cohort when all adolescents were to have a 
STI urine screen, just over half of the patients (n=9, 56%) completed the diagnostic test.  
Of the STI urine screens in this cohort, 22% (n=2) tested positive for chlamydia or 
gonorrhea.  In the second cohort when adolescents were to have a STI urine screen if they 
reported being sexually active, 100% (n=5) had the diagnostic test completed.  Of those, 
20% (n=1) of the five, tested positive for chlamydia. In the third cohort, 9% (n=1) 
screened positive for STI risk with the HEEADSSS assessment. This patient did have a 
urine sample ordered and collected, however, the specimen was not sent to the lab for 
testing due to miscommunication between the provider and the medical assistant. Overall, 
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it appeared about one in five (20%) had tested positive for an STI when screened 
routinely or if the adolescent reported sexual activity and is of clinical significance.  
Several limitations were identified in this study. The first limitation was the 
sample size. Only 11 adolescents were screened with the modified HEEADSSS 
assessment with one reflexive urine test that was ordered and collected, but not resulted. 
This made it difficult to determine the effectiveness of utilizing this for screening and 
determining if urine testing was needed. Also, the modified HEEADSSS screening was 
only conducted by the pediatric nurse practitioner. With only one provider in the practice 
using this screening tool, the sample may not have been representative of the entire 
practice. Another limitation was the urine sample obtained reflexively after the 
HEEADSSS assessment was ordered and collected but never resulted. No determination 
could be made between screening with the modified HEEADSSS assessment and 
reflexive urine testing as an alternative to the routine screening of all adolescents. 
Recommendations for further study include a larger sample size and the impact of 
age on reported sexual activity. While most patients denied sexual activity, the effect of 
age on sexual activity and rate of STI may be of interest. Regardless, the routine STI 
urine screening and STI urine screening only if sexual history was reported resulted in the 
identification of 20% of adolescents having an STI.  The modified HEEADSSS 
assessment with a reflexive STI urine screen was unable to be determined as effective in 
identifying those who may have had an STI; therefore, more study is needed. 
An implication for practice includes urine testing for STI to identify the presence 
of STI in some adolescents regardless of their sexual activity disclosures. Perhaps the 
availability of a urine sample before the provider has verbally screened the patient for 
ADOLESCENT STI SCREENINGS 18 
STI risk may aid in the completion of a STI urine screen when ordered. Finally, when 
sexual histories are obtained, STI risk may be better assessed if the parent or caregiver 
are asked to leave the room. The AAP (2017) recommended privacy when providing 
medical care to adolescents and to begin preparing pre-teens and parents on changes to 
the visit during the 12-year old well child visit.   
Conclusion 
In summary, most of the adolescent patients undergoing a well-child exam had a 
sexual history documented and nearly 1/5 of those adolescents tested positive for STI.  
While the effects of screening using a modified HEEADSSS assessment with reflexive 
STI urine screen were unable to be obtained in this study, screening of some sort 
improves the identification of STI.  The identification of adolescents having an STI may 
enhance early treatment and delay or eradicate long-term consequences occurring from 
an STI. Ideally, best practice is to obtain sexually histories without caregivers at the 
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Appendix A 
Table 1 
STI Urine Screen For All Adolescents (Cohort One) 
Variable n % Cumulative % 
Documented Sexual History       
    Yes 16 100 100 
Reported or Denied Sexual Activity       
    Denied 14 87.50 87.50 
    Neither Reported Nor Denied 1 6.25 93.75 
    Reported 1 6.25 100 
STI Testing Done       
    Yes 9 56.25 56.25 
    No 7 43.75 100 
Positive Urine Test       
    Yes 2 22.22 22.22 
    No 7 77.78 100 
Race       
    Black 6 37.50 37.50 
    White 7 43.75 81.25 
    Hispanic 3 18.75 100 
Gender       
    Female 9 56.25 56.25 
    Male 7 43.75 100 
 
Variable M SD n Mdn Mode 
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Appendix B 
Table 2 
STI Urine Screen Only For Adolescents Reporting Sexual Activity (Cohort Two) 
Variable n % Cumulative % 
Documented Sexual History       
    Yes 31 93.94 93.94 
    No 2 6.06 100 
Reported or Denied Sexual Activity       
    Denied 26 78.79 78.79 
    Reported 5 15.15 93.94 
    Neither Reported Nor Denied 2 6.06 100 
STI Testing Done       
    Yes 5 83.33 83.33 
    No 1 16.67 100 
Positive Urine Test       
    No 4 80 80 
    Yes 1 20 100 
Race       
    White 10 30.30 30.30 
    Black 17 51.52 81.82 
    Hispanic 4 12.12 93.94 
    Other 2 6.06 100 
Gender       
    Male 18 54.55 54.55 
    Female 15 45.45 100 
 
Variable M SD n Mdn Mode 
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Appendix C 
Table 3 
Cohort One and Two Combined 
Variable n % Cumulative % 
Documented Sexual History       
    Yes 46 93.88 93.88 
    No 3 6.12 100 
Reported or Denied Sexual Activity       
    Denied 40 81.63 81.63 
    Neither Reported Nor Denied 3 6.12 87.76 
    Reported 6 12.24 100 
STI Testing Done       
    Yes 14 28.57 28.57 
    No 35 71.43 100 
Positive Urine Test       
    Yes 3 21.43 21.43 
    No 11 78.57 100 
Gender       
    Female 24 48.98 48.98 
    Male 25 51.02 100 
Race       
    Black 23 46.94 46.94 
    White 17 34.69 81.63 
    Hispanic 7 14.29 95.92 
    Other 2 4.08 100 
 
Variable M SD n Mdn Mode 
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Appendix D 
Table 4 
STI Urine Screen For Adolescents Reporting Sexual Activity On HEEADSSS (Cohort 
Three) 
Variable n % Cumulative % 
Documented Sexual History        
    Yes 11 100 100 
Reported or Denied Sexual Activity        
   Denied 10 90.91 90.91 
   Reported 1 9.09 100 
STI Testing Done       
    No 10 90.91 90.91 
    Yes 1 9.09 100 
Race       
    White 1 9.09 9.09 
    Black 9 81.82 90.91 
    Hispanic 1 9.09 100 
Gender       
    Male 7 63.64 63.64 
    Female 4 36.36 100 
 
Variable M SD n Mdn Mode 
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Appendix E 
Figure 1. Chi-square Test of Cohort 1 and 2 – reported sexual activity & STI testing 
completed 
 
  STI Testing Done       
Reported or Denied Sexual Activity Yes No χ
2 df p 
Denied 10[11.43] 30[28.57] 5.72 2 .057 
Neither Reported or Denied 0[0.86] 3[2.14]       
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STI Testing 10 0 4





















Reported or Denied Sexual Actvitiy by STI Testing
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Appendix F 
Figure 2. Chi-square Test of Cohort 1 and 2 – reported sexual activity & positive urine 
test 
 
  Positive Urine Test       
Reported or Denied Sexual Activity Yes No χ
2 df p 
Denied 2[2.14] 8[7.86] 0.04 1 .837 
Reported 1[0.86] 3[3.14]       
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Positive STI Urine Test 2 1
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